Skip to main content

Peer Review reports

From: Study protocol of a phase II clinical trial (KSCC1501A) examining oxaliplatin + S-1 for treatment of HER2-negative advanced/recurrent gastric cancer previously untreated with chemotherapy

Original Submission
12 Mar 2016 Submitted Original manuscript
6 Sep 2016 Author responded Author comments - Hiroshi Saeki
Resubmission - Version 2
6 Sep 2016 Submitted Manuscript version 2
2 Feb 2017 Reviewed Reviewer Report - Riccardo Giampieri
11 Feb 2017 Reviewed Reviewer Report - Didier Meulendijks
16 Mar 2017 Author responded Author comments - Hiroshi Saeki
Resubmission - Version 3
16 Mar 2017 Submitted Manuscript version 3
3 Apr 2017 Reviewed Reviewer Report - Riccardo Giampieri
16 Nov 2017 Author responded Author comments - Hiroshi Saeki
Resubmission - Version 4
16 Nov 2017 Submitted Manuscript version 4
Publishing
19 Dec 2017 Editorially accepted
8 Jan 2018 Article published 10.1186/s12885-017-3937-6

You can find further information about peer review here.

Back to article page